Clinical Trial Update: Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris [Phase 4]

View source ↗

Summary

Phase 4 trial comparing dapsone gel 5% plus tazarotene cream 0.1% versus tazarotene cream 0.1% alone for facial acne vulgaris; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• ACZONE (DAPSONE)
• Tazorac Cream 0.1% (tazarotene)

Snippet

Sponsor: Allergan | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2011-10-31